Annual ROE
-348.39%
-198.78%-132.87%
September 30, 2024
Summary
- As of March 5, 2025, NMTC annual return on equity is -348.39%, with the most recent change of -198.78% (-132.87%) on September 30, 2024.
- During the last 3 years, NMTC annual ROE has fallen by -117.58% (-50.94%).
- NMTC annual ROE is now -141.66% below its all-time high of 836.36%, reached on December 31, 2011.
Performance
NMTC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-238.93%
+96.61%+28.79%
December 31, 2024
Summary
- As of March 5, 2025, NMTC quarterly return on equity is -238.93%, with the most recent change of +96.61% (+28.79%) on December 31, 2024.
- Over the past year, NMTC quarterly ROE has dropped by -0.86% (-0.36%).
- NMTC quarterly ROE is now -111.75% below its all-time high of 2034.17%, reached on June 30, 2017.
Performance
NMTC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NMTC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -132.9% | -0.4% |
| 3 y3 years | -50.9% | -0.4% |
| 5 y5 years | -163.6% | -0.4% |
NMTC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -181.5% | at low | -207.7% | +28.8% |
| 5 y | 5-year | -163.6% | +89.4% | -130.7% | +79.2% |
| alltime | all time | -141.7% | +89.4% | -111.8% | +79.2% |
NeuroOne Medical Technologies ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -238.93%(-28.8%) |
| Sep 2024 | -348.39%(+132.9%) | -335.54%(+19.0%) |
| Jun 2024 | - | -282.05%(+5.6%) |
| Mar 2024 | - | -267.01%(+12.2%) |
| Dec 2023 | - | -238.07%(+34.4%) |
| Sep 2023 | -149.61%(+20.9%) | -177.11%(+32.8%) |
| Jun 2023 | - | -133.41%(+33.7%) |
| Mar 2023 | - | -99.78%(+28.5%) |
| Dec 2022 | - | -77.66%(-13.3%) |
| Sep 2022 | -123.77%(-46.4%) | -89.53%(-12.4%) |
| Jun 2022 | - | -102.26%(-1.2%) |
| Mar 2022 | - | -103.55%(-16.3%) |
| Dec 2021 | - | -123.74%(-26.0%) |
| Sep 2021 | -230.81%(-93.0%) | -167.23%(-18.2%) |
| Jun 2021 | - | -204.32%(-82.2%) |
| Mar 2021 | - | -1149.94%(-247.8%) |
| Dec 2020 | - | 777.82%(+66.2%) |
| Sep 2020 | -3292.36%(-700.9%) | 468.01%(+21.3%) |
| Jun 2020 | - | 385.71%(+18.5%) |
| Mar 2020 | - | 325.39%(-54.1%) |
| Dec 2019 | - | 708.99%(+57.5%) |
| Sep 2019 | 547.93%(+369.2%) | 450.24%(+32.4%) |
| Jun 2019 | - | 340.16%(+177.3%) |
| Mar 2019 | - | 122.67%(+92.0%) |
| Dec 2018 | - | 63.90%(-37.1%) |
| Sep 2018 | 116.77%(+16.3%) | - |
| Jun 2018 | - | 101.62%(-32.6%) |
| Mar 2018 | - | 150.73%(-34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | 100.43%(+459.2%) | 229.96%(-22.0%) |
| Sep 2017 | - | 295.00%(-85.5%) |
| Jun 2017 | - | 2034.17%(+104.5%) |
| Mar 2017 | - | 994.48%(+213.8%) |
| Dec 2016 | 17.96%(-76.7%) | 316.90%(+403.2%) |
| Sep 2016 | - | 62.98%(-17.5%) |
| Jun 2016 | - | 76.33%(-9.1%) |
| Mar 2016 | - | 83.98%(-20.7%) |
| Dec 2015 | 77.18%(-24.5%) | 105.94%(-5.6%) |
| Sep 2015 | - | 112.23%(-13.6%) |
| Jun 2015 | - | 129.93%(-14.1%) |
| Mar 2015 | - | 151.26%(-12.6%) |
| Dec 2014 | 102.26%(+1.3%) | 173.00%(+16.0%) |
| Sep 2014 | - | 149.11%(+7.2%) |
| Jun 2014 | - | 139.07%(-2.9%) |
| Mar 2014 | - | 143.22%(+19.5%) |
| Dec 2013 | 100.99%(+24.1%) | 119.84%(-8.0%) |
| Sep 2013 | - | 130.33%(-13.2%) |
| Jun 2013 | - | 150.13%(+94.6%) |
| Mar 2013 | - | 77.15%(-27.9%) |
| Dec 2012 | 81.40%(-90.3%) | 106.97%(-63.0%) |
| Sep 2012 | - | 288.78%(-7.2%) |
| Jun 2012 | - | 311.24%(+7.5%) |
| Mar 2012 | - | 289.62%(-3.1%) |
| Dec 2011 | 836.36%(+499.4%) | 298.92%(+127.0%) |
| Sep 2011 | - | 131.71%(-20.1%) |
| Jun 2011 | - | 164.85%(-53.4%) |
| Mar 2011 | - | 353.49%(+78.8%) |
| Dec 2010 | 139.53% | 197.67% |
FAQ
- What is NeuroOne Medical Technologies annual return on equity?
- What is the all time high annual ROE for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual ROE year-on-year change?
- What is NeuroOne Medical Technologies quarterly return on equity?
- What is the all time high quarterly ROE for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly ROE year-on-year change?
What is NeuroOne Medical Technologies annual return on equity?
The current annual ROE of NMTC is -348.39%
What is the all time high annual ROE for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual return on equity is 836.36%
What is NeuroOne Medical Technologies annual ROE year-on-year change?
Over the past year, NMTC annual return on equity has changed by -198.78% (-132.87%)
What is NeuroOne Medical Technologies quarterly return on equity?
The current quarterly ROE of NMTC is -238.93%
What is the all time high quarterly ROE for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly return on equity is 2034.17%
What is NeuroOne Medical Technologies quarterly ROE year-on-year change?
Over the past year, NMTC quarterly return on equity has changed by -0.86% (-0.36%)